InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by BAKER G LEONARD JR, Director. Officer active across 2 companies, notably Corcept Therapeutics INC. In total, 4 reports have been published. Total volume traded: €1.8m. The latest transaction was filed on 11 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€884,36650,000 shares@ €17.68730.024% mcap100.0% of flow
Common Stock
SEC:0001225208-21-009444·
Ideal exit: 8 Mar 2022 (T+270)
€884,36650,000 shares@ €17.68730.015% mcap73.3% of flow
Common Stock
SEC:0001225208-21-009444:0·
Ideal exit: 8 Mar 2022 (T+270)
€160,74930,000 shares@ €5.3583100.0% of flow
Common Stock
SEC:0001225208-21-008372·
€160,74930,000 shares@ €5.35830.0027% mcap13.3% of flow
Common Stock
SEC:0001225208-21-008372:0·
4 of 4 declarations
About BAKER G LEONARD JR
Leonard G. Baker Jr. is a Director at CORCEPT THERAPEUTICS INC. As a board member, he contributes to the governance of the company and strategic decision-making. Leonard brings valuable expertise in the biotechnology field, helping CORCEPT navigate a complex environment and focus on innovation. His commitment to excellence is an asset to the company.
